Production (Stage)
Pasithea Therapeutics Corp.
KTTA
$0.69
$0.00070.10%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -55.52% | -57.61% | -52.20% | -70.10% | -59.85% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -40.18% | 40.16% | -67.59% | -30.00% | 24.24% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 55.35% | 36.49% | -7.70% | -76.85% | -71.22% |
Total Current Assets | -53.57% | -55.86% | -52.92% | -69.17% | -57.60% |
|
|||||
Total Current Assets | -53.57% | -55.86% | -52.92% | -69.17% | -57.60% |
Net Property, Plant & Equipment | -30.27% | -44.54% | -75.76% | -77.78% | -73.48% |
Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Intangibles | -8.10% | -7.93% | -7.78% | -7.63% | -7.49% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -34.58% | -38.49% | -39.21% | -53.70% | -46.70% |
|
|||||
Total Accounts Payable | -45.53% | -56.12% | -64.68% | -27.58% | 68.15% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -80.00% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -35.35% | -57.48% | -67.69% | -37.42% | 16.25% |
|
|||||
Total Current Liabilities | -35.35% | -57.48% | -67.69% | -37.42% | 16.25% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 47.83% | 92.18% | 462.20% | 25.91% | -88.16% |
Total Liabilities | -33.45% | -52.84% | -63.92% | -41.85% | -13.24% |
|
|||||
Common Stock & APIC | 11.95% | 9.62% | 9.55% | -4.85% | -4.78% |
Retained Earnings | -35.65% | -40.39% | -53.30% | -61.47% | -71.13% |
Treasury Stock & Other | -- | -53.19% | -358.44% | -134.29% | -70.97% |
Total Common Equity | -34.73% | -36.82% | -37.22% | -54.55% | -49.19% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -34.73% | -36.82% | -37.22% | -54.55% | -49.19% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -34.73% | -36.82% | -37.22% | -54.55% | -49.19% |
|